Floatz logo

Hcg

Ovarian Hyperstimulation Syndrome

UConn HealthPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Ovarian Hyperstimulation Syndrome cohort.

Asset / SponsorPhaseRating
Ganirelix
Eugonia
Phase 4BB
Hcq
Aljazeera Hospital
N/AD
Degarelix
Bioroma
D
Cabergoline
Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
N/AD

Same molecule, other indications

Hcg is also rated in:

polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →
infertility disorderDormant
BBB
Indicative ·
78 / 100
View asset →
In Vitro FertilizationDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →